News

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior Vice President and Head of Clinical Development

AffyImmune Therapeutics to Present Poster at American Association for Cancer Research Annual Meeting

AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital

AffyImmune Therapeutics to Present Initial Clinical Results at Upcoming CAR-TCR Summit

AffyImmune Therapeutics Announces Hiring of Matt Britz as Senior Vice President of Business Development

AffyImmune Therapeutics Announces Addition of Dr. Jim Mulé to its Scientific Advisory Board

Inquiries

Legal